Liu C, Bayer A, Cosgrove SE, et al.
Department of Medicine, Division of Infectious Diseases, University of California-San Francisco, San Francisco, California 94102, USA. email@example.com
SourceClin Infect Dis 2011 Feb 1; 52(3)
Evidence-based guidelines for the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections were prepared by an Expert Panel of the Infectious Diseases Society of America (IDSA). The guidelines are intended for use by health care providers who care for adult and pediatric patients with MRSA infections. The guidelines discuss the management of a variety of clinical syndromes associated with MRSA disease, including skin and soft tissue infections (SSTI), bacteremia and endocarditis, pneumonia, bone and joint infections, and central nervous system (CNS) infections. Recommendations are provided regarding vancomycin dosing and monitoring, management of infections due to MRSA strains with reduced susceptibility to vancomycin, and vancomycin treatment failures.
MeshAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsChildChild, PreschoolHumansInfantInfant, NewbornMethicillin-Resistant Staphylococcus aureusMiddle AgedStaphylococcal InfectionsUnited StatesVancomycinYoung Adult
Journal Article Practice Guideline Research Support, Non-U.S. Gov't